Article

Novel anti-collagenolytic regimen applied for treating stage IV DLK

A new treatment strategy consisting of oral doxycycline and topical sodium citrate 10% may have a positive role in the treatment of post-LASIK inflammatory conditions characterized by increased collagenolytic activities, said Elias F. Jarade, MD.

Related Videos
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
4 experts are featured in this series.
Bonnie An Henderson, MD, and EnVision Summit 2025 preview
Related Content
Avirmax Biopharma doses first patient in phase I/IIa clinical trial of ABI-110
November 25th 2024

Avirmax Biopharma doses first patient in phase I/IIa clinical trial of ABI-110

EnVision Summit 2025: Advancing Ophthalmology and Optometry Together
November 19th 2024

Connect, learn, and innovate in a family-friendly atmosphere: What to expect at EnVision Summit 2025

Next-generation sequencing in ocular oncology brings advances in diagnosis, management
November 25th 2024

Next-generation sequencing in ocular oncology brings advances in diagnosis, management

Robert Chang, MD, discusses the impact of large language models on glaucoma care and AI in ophthalmology
November 5th 2024

Innovation Series: Putting the buzz of large language models in ophthalmology into perspective with Robert T. Chang, MD

NHS introduces OCT scans nationwide to improve diabetic eye care
November 24th 2024

NHS introduces OCT scans nationwide to improve diabetic eye care

Harrow expands patient access to eyecare medications with price reductions and GoodRx partnership
November 23rd 2024

Harrow expands patient access to eyecare medications with price reductions and GoodRx partnership

© 2024 MJH Life Sciences

All rights reserved.